Table 3.
Moderate correlation | |||||
---|---|---|---|---|---|
Variable | Correlation coefficient (Spearman’s rho, ρ) | ||||
TLG | |||||
4 | 8 | 16 | 32 | 64 | |
Intensity variability | 0.529 | 0.519 | 0.530 | 0.565 | 0.581 |
Run-length variability | 0.632 | 0.700 | 0.677 | 0.670 | 0.681 |
Maximum SUV | 0.530 | 0.530 | 0.528 | 0.527 | 0.530 |
Mean SUV | 0.502 | 0.502 | 0.500 | 0.502 | 0.502 |
SUV variance | 0.583 | 0.583 | 0.579 | 0.587 | 0.583 |
SUV SD | 0.582 | 0.582 | 0.546 | 0.590 | 0.582 |
Surface area | |||||
Entropy | –0.526 | –0.531 | –0.520 | –0.553 | –0.543 |
Homogeneity | 0.543 | 0.545 | 0.527 | 0.560 | 0.539 |
Inverse difference moment | 0.543 | 0.547 | 0.531 | 0.557 | 0.504 |
Tumour volume | 0.635 | 0.635 | 0.627 | 0.641 | 0.635 |
MTV | |||||
Long-run emphasis | 0.5 | 0.501 | 0.588 | 0.672 | 0.634 |
Low-intensity long-run emphasis | 0.5 | 0.503 | 0.593 | 0.677 | 0.636 |
Surface area | 0.635 | 0.635 | 0.627 | 0.641 | 0.635 |
SUVmean | |||||
SUV variance | 0.655 | 0.655 | 0.636 | 0.653 | 0.655 |
TLG | 0.502 | 0.502 | 0.501 | 0.502 | 0.502 |
SUVmax | |||||
TLG | 0.530 | 0.530 | 0.525 | 0.527 | 0.530 |
TLG – total lesion glycolysis, SUV – standardised uptake value, MTV – metabolic tumour volume